"From theory to therapy: Balancing evidence in managing common ailments" is the title of a new FIP Insight Board report launched today.

It explores how pharmacists apply scientific evidence in community pharmacy practice, such as in pain management, respiratory care, and reflux treatment.

The report identifies key challenges, such as variability in clinical guidelines, limited access to real-world data, and commercial pressures on medicine adoption. It also outlines strategies to improve decision-making through continuous professional development (CPD), regulatory advancements, and digital tools.

By tackling these issues, FIP aims to enhance pharmacists' role in optimising patient care and advancing evidence-based practice.